Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.

Autor: Antonelli L; Department of Urology, Luzerner Kantonsspital, University of Lucerne, Lucerne, Switzerland.; Department of Urology, Policlinico Umberto I, Sapienza University, Rome, Italy., Ardizzone D; University of Lucerne, Lucerne, Switzerland., Tachibana I; Department of Urology, Indiana University School of Medicine, Indianapolis, IN., Adra N; Division of Medical Oncology, Indiana University School of Medicine, Indianapolis, IN., Cary C; Department of Urology, Indiana University School of Medicine, Indianapolis, IN., Hugar L; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL., Sexton WJ; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL., Bagrodia A; Department of Urology, University of California, San Diego, CA.; The University of Texas Southwestern, Dallas, TX., Mego M; Department of Oncology, Comenius University, National Cancer Institute, Bratislava, Slovak Republic., Daneshmand S; Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA., Nicolai N; Urologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Nazzani S; Urologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Giannatempo P; Urologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Franza A; Urologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Heidenreich A; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University of Cologne, Faculty of Medicine and University of Cologne, Cologne, Germany.; Department of Urology, Medical University, Vienna, Austria., Paffenholz P; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University of Cologne, Faculty of Medicine and University of Cologne, Cologne, Germany., Saoud R; Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, IL., Eggener S; Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, IL., Ho M; Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, IL., Oswald N; Department of Urology, Mayo Clinic, Scottsdale, AZ., Olson K; Department of Urology, Mayo Clinic, Scottsdale, AZ., Tryakin A; N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation., Fedyanin M; N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation., Naoun N; Institut Gustave Roussy, Villejuif, France., Javaud C; Institut Gustave Roussy, Villejuif, France., Cazzaniga W; Department of Urology, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Nicol D; Department of Urology, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Institute of Cancer Research, London, United Kingdom., Gerdtsson A; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institutet, Stockholm, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden., Tandstad T; The Cancer Clinic, St Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway., Fizazi K; Institut Gustave Roussy, Villejuif, France., Fankhauser CD; Department of Urology, Luzerner Kantonsspital, University of Lucerne, Lucerne, Switzerland.; University of Lucerne, Lucerne, Switzerland.; University of Zurich, Zurich, Switzerland.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 01; Vol. 41 (34), pp. 5296-5305. Date of Electronic Publication: 2023 Sep 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review.

Autor: Notarfrancesco M; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Switzerland., Fankhauser CD; Department of Urology, Luzerner Kantonsspital, Luzern, Switzerland., Lorch A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Ardizzone D; Department of Urology, University Hospital Zurich, Zurich, Switzerland., Helnwein S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland., Hoch D; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland., Hermanns T; Department of Urology, University Hospital Zurich, Zurich, Switzerland., Thalmann G; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Switzerland., Beyer J; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Publikováno v: Swiss medical weekly [Swiss Med Wkly] 2023 Apr 10; Vol. 153, pp. 40053. Date of Electronic Publication: 2023 Apr 10.

Is conservative management safe in patients with acute ureterolithiasis and perirenal stranding?

Autor: Grossmann NC; Department of Urology, University Hospital Zurich, Frauenklinikstr. 10, 8091, Zurich, Switzerland. nico.grossmann@gmail.com., Ardizzone D; Department of Urology, University Hospital Zurich, Frauenklinikstr. 10, 8091, Zurich, Switzerland., Hermanns T; Department of Urology, University Hospital Zurich, Frauenklinikstr. 10, 8091, Zurich, Switzerland., Keller EX; Department of Urology, University Hospital Zurich, Frauenklinikstr. 10, 8091, Zurich, Switzerland., Fankhauser CD; Department of Urology, University Hospital Zurich, Frauenklinikstr. 10, 8091, Zurich, Switzerland.

Publikováno v: Urolithiasis [Urolithiasis] 2023 Feb 22; Vol. 51 (1), pp. 40. Date of Electronic Publication: 2023 Feb 22.

O6 - Risk of residual teratoma after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumor and IGCCCG intermediate/poor prognosis: A multi-institutional retrospective cohort study

Autor: Antonelli, L., Ardizzone, D., Ravi, P., Sweeney, C., Bagrodia, A., Mego, M., Douglawi, A., Campanelli Palmer, T., Nazzani, S., Giannatempo, P., Franza, A., Paffenholz, P., Saoud, R., Eggener, S., Ho, M., Oswald, N., Olson, K., Tryakin, A., Naoun, N., Javaud, C., Fizazi, K., Cary, C., Fankhauser, C.D.

Publikováno v: In European Urology Open Science November 2022 45 Supplement 2:S53-S53